# PLYX (Polaryx Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Polaryx Therapeutics, Inc. reported $8.61M in total assets and a net loss of $8.75M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PLYX
- Markdown: https://convexityos.com/fundamentals/PLYX.md
- SEC CIK: 0002075320
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002075320&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$7.58M | Operating profit |
| Net Income | FY 2025 | -$8.75M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.18 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $8.44M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Research & Development | $6.27M | $2.81M |
| Total Operating Expenses | $7.82M | $4.35M |
| **Operating Income** | -$7.82M | -$4.35M |
| Income Before Tax | -$8.98M | -$30.36M |
| **Net Income** | -$8.98M | -$30.36M |
| Basic EPS | -$0.20 | -$0.89 |
| **Diluted EPS** | -$0.20 | -$0.89 |
| Basic Shares Outstanding | 45.4M | 34.2M |
| Diluted Shares Outstanding | 45.4M | 34.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.45M | $719K | $679K | $560K | $514K | $476K | $4.72M |
| Total Operating Expenses | $3.33M | $1.38M | $1.96M | $911K | $974K | $884K | $5.05M |
| **Operating Income** | -$3.33M | -$1.38M | -$1.96M | -$911K | -$974K | -$884K | -$5.05M |
| **Net Income** | -$3.33M | -$1.38M | -$2.54M | -$1.50M | -$1.43M | -$1.01M | -$5.05M |
| Basic EPS | -$0.07 | -$0.03 | -$0.05 | -- | -$0.03 | -$0.02 | -$0.11 |
| **Diluted EPS** | -$0.07 | -$0.03 | -$0.05 | -- | -$0.03 | -$0.02 | -$0.11 |
| Basic Shares Outstanding | 49.8M | 48.3M | 47.2M | -- | 45.8M | 44.7M | 44.3M |
| Diluted Shares Outstanding | 49.8M | 48.3M | 47.2M | -- | 45.8M | 44.7M | 44.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $5.14M | $4.62M |
| **Cash & Short-Term Investments** | $5.14M | $4.62M |
| Other Current Assets | $27K | -- |
| **Total Current Assets** | $5.17M | $5.00M |
| **Total Non-Current Assets** | $0 | $0 |
| **Total Assets** | $5.17M | $5.00M |
| Accounts Payable | $470K | $72K |
| **Total Current Liabilities** | $605K | $289K |
| **Total Non-Current Liabilities** | $0 | $0 |
| **Total Liabilities** | $605K | $289K |
| Common Stock | $5.0K | $4.0K |
| Retained Earnings | -$99.64M | -$90.65M |
| **Total Stockholders' Equity** | $4.57M | $4.71M |
| Total Equity | $4.57M | $4.71M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.44M | $11.54M | $3.08M | $5.14M | $4.62M |
| **Cash & Short-Term Investments** | $8.44M | $11.54M | $3.08M | $5.14M | $4.62M |
| Other Current Assets | $18K | -- | $33K | $27K | -- |
| **Total Current Assets** | $8.61M | $11.81M | $3.50M | $5.17M | $5.00M |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $8.61M | $11.81M | $3.50M | $5.17M | $5.00M |
| Accounts Payable | $783K | $683K | $850K | $470K | $72K |
| **Total Current Liabilities** | $999K | $873K | $1.01M | $605K | $289K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $999K | $873K | $1.01M | $605K | $289K |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K |
| Retained Earnings | -$106.9M | -$103.6M | -$102.2M | -$99.64M | -$90.65M |
| **Total Stockholders' Equity** | $7.61M | $10.94M | $2.49M | $4.57M | $4.71M |
| Total Equity | $7.61M | $10.94M | $2.49M | $4.57M | $4.71M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$8.98M | -$30.36M |
| Stock-Based Compensation | $4.72M | $2.40M |
| Change in Payables | $398K | -$401K |
| **Operating Cash Flow** | -$3.94M | -$2.57M |
| Common Stock Issued | $4.49M | $7.32M |
| **Financing Cash Flow** | $4.47M | $7.19M |
| **Net Change in Cash** | $522K | $4.62M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.33M | -$1.38M | -$2.54M | -$1.50M | -$1.43M | -$1.01M | -$5.05M |
| Stock-Based Compensation | $0 | $0 | $467K | $57K | $108K | $109K | $4.45M |
| Change in Payables | $100K | -$167K | $380K | -$26K | $338K | $103K | -$17K |
| **Operating Cash Flow** | -$3.10M | -$1.37M | -$2.06M | -$1.49M | -$887K | -$858K | -$709K |
| Common Stock Issued | -- | -- | -- | $759K | $3.48M | $0 | $250K |
| **Financing Cash Flow** | -- | -- | -- | $888K | $3.33M | $0 | $250K |
| **Net Change in Cash** | -$3.10M | $8.46M | -$2.06M | -$602K | $2.44M | -$858K | -$459K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Return on Equity (ROE) | -196.8% | -644.2% |
| Return on Assets (ROA) | -173.8% | -607.0% |
| Current Ratio | 8.55x | 17.30x |
| Quick Ratio | 8.50x | 15.99x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -114.9% | -62.6% | -260.3% | -196.8% | -- | -- | -- |
| Return on Assets (ROA) | -101.6% | -58.0% | -185.0% | -173.8% | -- | -- | -- |
| Current Ratio | 8.62x | 13.53x | 3.45x | 8.55x | -- | -- | -- |
| Quick Ratio | 8.45x | 13.22x | 3.04x | 8.50x | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
